- About Us
- NVHR Hepatitis C Resources
- NVHR Hepatitis C State Specific Resources Pages
- More than Tested, Cured Project
- Hepatitis C Treatment Access
HCV panel on Sept 19th during Congressional Black Caucus Foundation Annual Legislative Conference
Corporate Hepatitis Alliance (CHA)
“The Silent Epidemic”
Understanding hepatitis C (HCV) and the crisis among African American Communities
Thursday September 19th
4:00 PM to 5:30 PM
Walter E. Washington Convention Center – Room 140-A
801 Mount Vernon Place, NW * Washington, DC 20001
To register or for more information:: CHAInfo@CorpHepatitisAlliance.com
Please note: A registration fee is not required to attend this event only a conference badge is required to enter.
Please go to any registration table and ask for a conference badge to attend “The Silent Epidemic” Panel Discussion Room 140-A.
Dr. John Ward, Director of the Division of Viral Hepatitis, NCHHSTP, CDC Dr. Charles Howell, Professor and Director of Hepatology Research, University of Maryland Dr. Stephen R. Lee, Executive Vice President & Chief Science Officer, OraSure Technologies, Inc. Ms. Barbara H. McGovern, MA, Associate Medical Director, AbbVie Pharmaceuticals Mr. Christopher H. Bates, MPA, Director, Department of HHS, Office of HIV/AIDS Policy (OHAP) Ms. Hadiyah Charles, MA, Hepatitis C Advocacy Manager, Harm Reduction Coalition
The Mayor Johnny Ford of Tuskegee, Alabama, B.A., MBA, Founder and the Director General of The World Conference of Mayors (WCM), President-emeritus and Founder of the National Conference of Black Mayors
This event is sponsored by AbbVie Pharmaceuticals • OraSure Technologies, Inc.
Corporate Hepatitis Alliance Participating Industry Partners;
AbbVie Pharmaceuticals • Achillion Pharmaceuticals • Alere, Inc. • Biotest Pharmaceuticals Corporation • Boehringer Ingelheim Pharmaceuticals, Inc. Bristol-Myers Squibb • Genentech • Gilead Sciences, Inc. • GlaxoSmithKline • Health & Medicine Council of Washington • Johnson & Johnson • Kadmon Pharmaceuticals • Merck & Co. • OraSure Technologies, Inc. • Vertex Pharmaceuticals